About Us

Founded in 1995, Lawley Pharmaceuticals, an Australian Perth-based privately owned company, has become a world leader in the research and development of transdermal testosterone and progesterone creams for use in men and women.

In 2020 Lawley’s past two decades of dedication and perseverance has resulted in Australian regulatory approvals that represent global breakthroughs in male and female testosterone treatment options.

Our low dose scrotal testosterone for men provides the dual benefit over existing therapies of an enhanced safety profile from third-party passive transfer at a substantially reduced cost of treatment to patients and healthcare funders.

Our female testosterone cream represents a global regulatory first for the management of hypoactive sexual desire dysfunction in postmenopausal women.